Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00108290 · ClinicalTrials.gov registry record · Phase 2
Chemotherapy, Hormone Therapy, and Surgery to Remove the Prostate Gland in Patients With High Risk Prostate Cancer
A Phase 2 study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00108290: Completed Phase 2 study, sponsored by US Department of Veterans Affairs.
NCT00108290 is a Phase 2 study that has completed, run by US Department of Veterans Affairs. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00108290, a Phase 2 study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
In men with prostate cancer who do not have evidence of spread to bone or other sites on computed axial tomography (CAT) scan/bone scan but are still at significant risk of failing treatment with surgery or radiation alone, a combination of chemotherapy and hormone therapy is being given for 6 months followed by surgery to remove the prostate.
Interventions
- DRUG Chemotherapy
Trial Details
| Field | Value |
|---|---|
| Start Date | 2004-04 |
| Est. Completion | 2007-03 |
| Phase | Phase 2 |
What the finished NCT00108290 record still lists
NCT00108290 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Chemotherapy is the first listed.
NCT00108290 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00108290 about?
NCT00108290 is a clinical study titled "Chemotherapy, Hormone Therapy, and Surgery to Remove the Prostate Gland in Patients With High Risk Prostate Cancer". In men with prostate cancer who do not have evidence of spread to bone or other sites on computed axial tomography (CAT) scan/bone scan but are still at significant risk of failing treatment with surgery or radiation alone, a combination of chemotherapy and hormone therapy is being given for 6 month...
What is the current status of trial NCT00108290?
This trial is currently completed. It is a Phase 2 study. The study started on 2004-04. Estimated completion is 2007-03.
What interventions are being tested in trial NCT00108290?
The interventions under investigation include: Chemotherapy (DRUG).
Who is sponsoring clinical trial NCT00108290?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia